An Open-label Study of AZD0120 in Adults With Multiple Sclerosis

Research Site, Tucson, Arizona, United States

Research Site, Aurora, Colorado, United States

Research Site, Washington D.C., District of Columbia, United States

Research Site, St Louis, Missouri, United States

Research Site, New York, New York, United States

Research Site, New York, New York, United States

Research Site, Cleveland, Ohio, United States

Research Site, Seattle, Washington, United States

Research Site, Milwaukee, Wisconsin, United States

Research Site, Liverpool, Australia

Research Site, Melbourne, Australia

Research Site, Melbourne, Australia

Research Site, Waratah, Australia

Research Site, Montreal, Quebec, Canada

Research Site, Leipzig, Germany

Research Site, Magdeburg, Germany

Research Site, Würzburg, Germany

Research Site, Cambridge, United Kingdom

Research Site, London, United Kingdom